Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1980 Feb;35(2):101–106. doi: 10.1136/thx.35.2.101

Diagnostic and therapeutic implications of ectopic hormone production in small cell carcinoma of the lung

Mogens Hansen 1,2,3,4, Mogens Hammer 1,2,3,4, Lotte Hummer 1,2,3,4
PMCID: PMC471231  PMID: 6246651

Abstract

In 75 unselected and untreated patients with small cell carcinoma of the lung, plasma ACTH, serum calcitonin, and antidiuretic hormone (ADH) in plasma and urine were related to corresponding clinical symptoms and biochemical findings at the time of diagnosis. The significance of elevated concentrations of these substances in relation to treatment was also investigated. Plasma ACTH concentrations were increased in 22 patients (29%), and 25 patients (33%) were considered to have inappropriate ADH secretion. Only one patient had definite hypokalaemic alkalosis, and one patient pronounced hyponatraemia, with associated clinical syndromes of ectopic ACTH and ADH secretion. Serum calcitonin concentrations were increased in 48 patients (65%). No related clinical symptoms were disclosed, and all these patients had normal serum calcium concentrations. Thirty-three of 66 patients (50%) had raised levels of free cortisol in a 24-hour urine and these levels were significantly related to plasma ACTH concentrations. The median survival was slightly shorter in patients with increased values of the three substances, but this was not related to increased plasma ACTH concentrations and was not statistically significant. Survival rates and results of treatment were independent of the pretreatment levels of the three substances.

Full text

PDF
101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMATRUDA T. T., Jr, MULROW P. J., GALLAGHER J. C., SAWYER W. H. CARCINOMA OF THE LUNG WITH INAPPROPRIATE ANTIDIURESIS. DEMONSTRATION OF ANTIDIURETIC-HORMONE-LIKE ACTIVITY IN TUMOR EXTRACT. N Engl J Med. 1963 Sep 12;269:544–549. doi: 10.1056/NEJM196309122691102. [DOI] [PubMed] [Google Scholar]
  2. Abe K., Adachi I., Miyakawa S., Tanaka M., Yamaguchi K., Tanaka N., Kameya T., Shimosato Y. Production of calcitonin, adrenocorticotropic hormone, and beta-melanocyte-stimulating hormone in tumors derived from amine precursor uptake and decarboxylation cells. Cancer Res. 1977 Nov;37(11):4190–4194. [PubMed] [Google Scholar]
  3. Almqvist S., Telenius-Berg M., Wästhed B. Serum calcitonin in medullary thyroid carcinoma. Radioimmunoassay technique and diagnostic value. Acta Med Scand. 1974 Sep;196(3):177–180. doi: 10.1111/j.0954-6820.1974.tb00992.x. [DOI] [PubMed] [Google Scholar]
  4. BAGSHAWE K. D. Hypokalaemia, carcinoma and Cushing's syndrome. Lancet. 1960 Aug 6;2(7145):284–287. doi: 10.1016/s0140-6736(60)91375-1. [DOI] [PubMed] [Google Scholar]
  5. BOWER B. F., GORDAN G. S. HORMONAL EFFECTS OF NONENDOCRINE TUMORS. Annu Rev Med. 1965;16:83–118. doi: 10.1146/annurev.me.16.020165.000503. [DOI] [PubMed] [Google Scholar]
  6. Bartter F. C., Schwartz W. B. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967 May;42(5):790–806. doi: 10.1016/0002-9343(67)90096-4. [DOI] [PubMed] [Google Scholar]
  7. Baylin S. B., Weisburger W. R., Eggleston J. C., Mendelsohn G., Beaven M. A., Abeloff M. D., Ettinger D. S. Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications. N Engl J Med. 1978 Jul 20;299(3):105–110. doi: 10.1056/NEJM197807202990301. [DOI] [PubMed] [Google Scholar]
  8. Bloomfield G. A., Holdaway I. M., Corrin B., Ratcliffe J. G., Rees G. M., Ellison M., Rees L. H. Lung tumours and ACTH production. Clin Endocrinol (Oxf) 1977 Feb;6(2):95–104. doi: 10.1111/j.1365-2265.1977.tb02000.x. [DOI] [PubMed] [Google Scholar]
  9. Christensen J. D., Jensen S. E. A comparative study on bioassay and radioimmunoassay of vasopressin in human urine. Acta Endocrinol (Copenh) 1978 Feb;87(2):283–291. doi: 10.1530/acta.0.0870283. [DOI] [PubMed] [Google Scholar]
  10. Coombes R. C., Ellison M. L., Neville A. M. Biochemical markers in bronchogenic carcinoma. Br J Dis Chest. 1978 Oct;72(4):263–287. [PubMed] [Google Scholar]
  11. HATCH H. B., Jr, SEGALOFF A., OCHSNER A. ADRENOCORTICAL FUNCTION IN BRONCHOGENIC CARCINOMA: STUDY OF 100 PATIENTS. Ann Surg. 1965 May;161:645–648. doi: 10.1097/00000658-196505000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hammer M. Radioimmunoassay of 8-arginine-vasopressin (antidiuretic hormone) in human plasma. Scand J Clin Lab Invest. 1978 Dec;38(8):707–716. doi: 10.1080/00365517809104877. [DOI] [PubMed] [Google Scholar]
  13. Hansen H. H., Dombernowsky P., Hansen M., Hirsch F. Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination. Ann Intern Med. 1978 Aug;89(2):177–181. doi: 10.7326/0003-4819-89-2-177. [DOI] [PubMed] [Google Scholar]
  14. Hansen M., Rehfeld J. F., Stadil F. Small cell carcinoma of the lung: relation of calcitonin to bone marrow metastases, parathormone and gastrin. Acta Med Scand. 1979;206(3):215–218. doi: 10.1111/j.0954-6820.1979.tb13497.x. [DOI] [PubMed] [Google Scholar]
  15. Horai R., Nishihara H., Tateishi R., Matsuda M., Hattori S. Oat-cell carcinoma of the lung simultaneously producing ACTH and serotonin. J Clin Endocrinol Metab. 1973 Aug;37(2):212–219. doi: 10.1210/jcem-37-2-212. [DOI] [PubMed] [Google Scholar]
  16. Kato Y., Ferguson T. B., Bennett D. E., Burford T. H. Oat cell carcinoma of the lung. A review of 138 cases. Cancer. 1969 Mar;23(3):517–524. doi: 10.1002/1097-0142(196903)23:3<517::aid-cncr2820230301>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  17. Kehlet H., Binder C., Nielsen M. D. Bestemmelse af frie urinkortikosteroider med kompetitiv proteinbindingsteknik ved Cushing's syndrom. Ugeskr Laeger. 1972 Nov 13;134(46):2438–2441. [PubMed] [Google Scholar]
  18. LIDDLE G. W., ISLAND D. P., NEY R. L., NICHOLSON W. E., SHIMIZU N. Nonpituitary neoplasms and Cushing's syndrome. Ectopic "adrenocorticotropin" produced by nonpituitary neoplasms as a cause of Cushing's syndrome. Arch Intern Med. 1963 Apr;111:471–475. doi: 10.1001/archinte.1963.03620280071011. [DOI] [PubMed] [Google Scholar]
  19. Lichter I., Sirett N. E. Serial measurement of plasma cortisol in lung cancer. Thorax. 1975 Feb;30(1):91–94. doi: 10.1136/thx.30.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Liddle G. W., Givens J. R., Nicholson W. E., Island D. P. The ectopic ACTH syndrome. Cancer Res. 1965 Aug;25(7):1057–1061. [PubMed] [Google Scholar]
  21. MEADOR C. K., LIDDLE G. W., ISLAND D. P., NICHOLSON W. E., LUCAS C. P., NUCKTON J. G., LUETSCHER J. A. Cause of Cushing's syndrome in patients with tumors arising from "nonendocrine" tissue. J Clin Endocrinol Metab. 1962 Jul;22:693–703. doi: 10.1210/jcem-22-7-693. [DOI] [PubMed] [Google Scholar]
  22. Morton J. J., Kelly P., Padfield P. L. Antidiuretic hormone in bronchogenic carcinoma. Clin Endocrinol (Oxf) 1978 Oct;9(4):357–370. doi: 10.1111/j.1365-2265.1978.tb02221.x. [DOI] [PubMed] [Google Scholar]
  23. O'Neal L. W., Kipnis D. M., Luse S. A., Lacy P. E., Jarett L. Secretion of various endocrine substances by ACTH-secreting tumors--gastrin, melanotropin, norepinephrine, serotonin, parathormone, vasopressin, glucagon. Cancer. 1968 Jun;21(6):1219–1232. doi: 10.1002/1097-0142(196806)21:6<1219::aid-cncr2820210625>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  24. PRUNTY F. T., BROOKS R. V., DUPRE J., GIMLETTE T. M., HUTCHINSON J. S., MCSWINEY R. R., MILLS I. H. ADRENOCORTICAL HYPERFUNCTION AND POTASSIUM METABOLISM IN PATIENTS WITH "NON- ENDOCRINE" TUMORS AND CUSHING'S SYNDROME. J Clin Endocrinol Metab. 1963 Aug;23:737–746. doi: 10.1210/jcem-23-8-737. [DOI] [PubMed] [Google Scholar]
  25. Padfield P. L., Morton J. J., Brown J. J., Lever A. F., Robertson J. I., Wood M., Fox R. Plasma arginine vasopressin in the syndrome of antidiuretic hormone excess associated with bronchogenic carcinoma. Am J Med. 1976 Dec;61(6):825–831. doi: 10.1016/0002-9343(76)90406-x. [DOI] [PubMed] [Google Scholar]
  26. Rees L. H., Bloomfield G. A., Rees G. M., Corrin B., Franks L. M., Ratcliffe J. G. Multiple hormones in a bronchial tumor. J Clin Endocrinol Metab. 1974 Jun;38(6):1090–1097. doi: 10.1210/jcem-38-6-1090. [DOI] [PubMed] [Google Scholar]
  27. Rees L. H., Ratcliffe J. G. Ectopic hormone production by non-endocrine tumours. Clin Endocrinol (Oxf) 1974 Jul;3(3):263–299. doi: 10.1111/j.1365-2265.1974.tb01801.x. [DOI] [PubMed] [Google Scholar]
  28. Ross E. J. Endocrine and metabolic manifestations of cancer. Br Med J. 1972 Mar 18;1(5802):735–738. doi: 10.1136/bmj.1.5802.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Said S. I. Endocrine role of the lung in disease. Am J Med. 1974 Sep;57(3):453–465. doi: 10.1016/0002-9343(74)90139-9. [DOI] [PubMed] [Google Scholar]
  30. Silva O. L., Becker K. L., Primack A., Doppman J., Snider R. H. Ectopic secretion of calcitonin by oat-cell carcinoma. N Engl J Med. 1974 May 16;290(20):1122–1124. doi: 10.1056/NEJM197405162902007. [DOI] [PubMed] [Google Scholar]
  31. Vorherr H. Para-endocrine tumor activity with emphasis on ectopic ADH secretion. Genetic, diagnostic, prognostic and therapeutic aspects. Oncology. 1974;29(5):382–416. doi: 10.1159/000224922. [DOI] [PubMed] [Google Scholar]
  32. WILSON H., LIPSETT M. B. Use of periodate oxidation in the clinical analysis of urine corticoids. Anal Biochem. 1963 Mar;5:217–225. doi: 10.1016/0003-2697(63)90119-2. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES